2019
DOI: 10.1007/s00066-019-01468-z
|View full text |Cite
|
Sign up to set email alerts
|

Influence of XRCC4 expression by breast cancer cells on ipsilateral recurrence after breast-conserving therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 30 publications
0
9
0
Order By: Relevance
“…Also, in studies on gastric and breast cancerous tissues, an increase in the XRCC4 gene expression was reported (21,22). Kitagawa et al introduced the expression of the XRCC4 gene as a biomarker to detect the recurrence of breast cancer (22). Overexpression of the DCLRE1C gene, which rises through recruitment of NHEJ repair pathway, was previously reported in lung cancer (23).…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…Also, in studies on gastric and breast cancerous tissues, an increase in the XRCC4 gene expression was reported (21,22). Kitagawa et al introduced the expression of the XRCC4 gene as a biomarker to detect the recurrence of breast cancer (22). Overexpression of the DCLRE1C gene, which rises through recruitment of NHEJ repair pathway, was previously reported in lung cancer (23).…”
Section: Discussionmentioning
confidence: 97%
“…It has also been suggested increased expression is because of the ine ciency of the HR repair pathway (20). Also, in studies on gastric and breast cancerous tissues, an increase in the XRCC4 gene expression was reported (21,22). Kitagawa et al introduced the expression of the XRCC4 gene as a biomarker to detect the recurrence of breast cancer (22).…”
Section: Discussionmentioning
confidence: 99%
“…Also, in studies on gastric and breast cancerous tissues, an increase in the XRCC4 gene expression was reported (20,21). Kitagawa et al introduced the expression of the XRCC4 gene as a biomarker to detect the recurrence of breast cancer (21). Overexpression of the DCLRE1C gene, which rises through recruitment of NHEJ repair pathway, was previously reported in lung cancer (22).…”
Section: Discussionmentioning
confidence: 97%
“…It has also been suggested increased expression is because of the ine ciency of the HR repair pathway (19). Also, in studies on gastric and breast cancerous tissues, an increase in the XRCC4 gene expression was reported (20,21). Kitagawa et al introduced the expression of the XRCC4 gene as a biomarker to detect the recurrence of breast cancer (21).…”
Section: Discussionmentioning
confidence: 99%
“…X-ray repair cross complementing 4 (XRCC4), an important DNA repair gene involved in nonhomologous end-joining (NHEJ) repair pathway, plays a scaffold function via stabilizing and localizing DNA repair enzymes LIG IV, Ku70/80 heterodimer, and the DNA-dependent protein kinase (DNA-PK) catalytic subunit (DNA-PKcs) in the ends of DNA double-stranded breaks (DSBs) during NHEJ [15,16]. In the past decades, growing reports have exhibited that the abnormal structures and functions of XRCC4 may alter the capacity of DNA repair and ultimately result in human diseases [17][18][19][20][21][22]. Several recent studies have also shown that the genetic alterations in the coding regions of XRCC4 can modify hepatocellular carcinoma (HCC) risk and prognosis [23][24][25][26][27].…”
Section: Introductionmentioning
confidence: 99%